This class groups research compounds that are studied for their relationship to mitochondrial signaling, cellular energy-sensing pathways (AMPK, sirtuins, NAD+ homeostasis) and adipose lipid metabolism. It includes a mitochondrial-genome-encoded peptide (MOTS-c), an endogenous redox coenzyme (NAD+), a small-molecule NNMT inhibitor (5-Amino-1MQ) and a synthetic C-terminal fragment of human growth hormone (AOD-9604). The published literature is predominantly in-vitro (cultured adipocytes, myoblasts, HEK293 and HepG2 cells) and rodent work in diet-induced obesity, ovariectomy, aging and injury models, together with mechanistic reviews of NAD+ biology. These materials are supplied for laboratory research only; the studies cited in the Research Library do not establish safety or efficacy in humans and nothing here should be read as a therapeutic or dosing recommendation.
Liv Pure supplies MOTS-c, NAD+, 5-Amino-1MQ and AOD-9604 as lyophilized research reagents; each listing shows the quantities available and links to its certificate of analysis where a lot has been tested. The published in-vitro and preclinical literature for every compound in this class, with PubMed links, is collected in the Mitochondrial & Metabolic Peptides section of the Research Library. All products are for in-vitro laboratory research only and are not for human or animal use.
Liv Pure supplies research-grade synthetic peptides and laboratory reagents to qualified researchers and institutions. Every lot ships with a lot-specific certificate of analysis.
Research Use Only • Lot-Specific COAs • Ships From the USA
© 2026 Liv Pure. All rights reserved.
All products provided by Liv Pure are intended solely for in-vitro laboratory research purposes. These materials are expressly forbidden for any form of human or animal use, ingestion, or administration, and all products are sold strictly for research, laboratory, or analytical purposes, not for human consumption. The products offered on this site are not formulated, designed, or intended to diagnose, cure, mitigate, treat, or prevent any disease or medical condition, and these statements have not been evaluated by the Food and Drug Administration. Liv Pure is a chemical supplier; it is not a compounding pharmacy or chemical compounding facility as defined under Section 503A of the Federal Food, Drug, and Cosmetic Act, nor an outsourcing facility as defined under Section 503B of the Act.
